In silico design of the M2 proton channel inhibitors of H1N1 virus

OnLine Journal of Biological Sciences

Volumn 13, Issue 1, 2013, Pages 1-12

  Tambunan, U S F ^a   Rahdiansyah, M R ^a   Parikesit, A A ^a  

^a UNIVERSITY OF INDONESIA   (Indonesia)

Author keywords

Amantadine; H1N1 virus; M2 channel; Molecular docking; Molecular dynamics

Indexed keywords

INFLUENZA A VIRUS; INFLUENZAVIRUS A; ORTHOMYXOVIRIDAE;

EID: 84876762807     PISSN: None     EISSN: 16084217     Source Type: Journal    
DOI: 10.3844/ojbsci.2013.1.12     Document Type: Article

References (51)

1. Abdussamad, J. and S. Aris-Brosou, 2011. The nonadaptive nature of the H1N1 2009 Swine flupandemic contrasts with the adaptive facilitation of transmission to a new host. BMC Evol. Biol., 11: 6-6. DOI: 10.1186/1471-2148-11-6
2. Alonso, H., A.A. Bliznyuk and J.E. Gready, 2006. Combining docking and molecular dynamic simulations in drug design. Medic. Res. Rev., 26: 531-568. DOI: 10.1002/med.20067
3. Arnold, K., L. Bordoli, J. Kopp and T. Schwede, 2006. The SWISS-MODEL Workspace: A web-based environment for protein structure homology modelling. Bioinformatics, 22: 195-201. DOI: 10.1093/bioinformatics/bti770
4. Ball, V. and C. Maechling, 2009. Isothermal microcalorimetry to investigate non specific interactions in biophysical chemistry. Int. J. Mol. Sci., 10: 3283-3315. DOI: 10.3390/ijms10083283
5. Betakova, T., 2007. M2 protein-a proton channel of influenza A virus. Curr. Pharm. Des., 13: 3231-3235. PMID: 18045172
6. Bright, R.A., D.K. Shay, B. Shu, N.J. Cox and A.I. Klimov, 2006. Adamantane resistance among influenza a viruses isolated early during the 2005-2006 influenza season in the united states. J. Am. Med. Assoc., 295: 891-894. DOI: 10.1001/jama.295.8.joc60020
7. Cady, S.D. and M. Hong, 2008. Amantadine-induced conformational and dynamical changes of the influenza M2 transmembrane proton channel. Proc. Nat. Acad. Sci. USA., 105: 1483-1488.
8. Chen, H., Y. Wu and G.A. Voth, 2007. Proton transport behavior through the influenza A M2 channel: insights from molecular simulation. Biophysical J., 93: 3470-3479. DOI: 10.1529/biophysj.107.105742
9. Chou, K.C., G.M. Maggiora, G. Nemethy and H.A. Scheraga, 1988. Energetics of the structure of the four-alpha-helix bundle in proteins. Proc. Nat. Acad. Sci., USA., 85: 4295-4299.
10. Chou, K.C., G.M. Maggiora and H.A. Scheraga, 1992. Role of loop-helix interactions in stabilizing four-helix bundle proteins. Proc. Nat. Acad. Sci. USA., 89: 7315-7319.
11. Cook, I.T., T.S. Leyh, S.A. Kadlubar and C.N. Falany, 2010. Structural rearrangement of SULT2A1: Effects on dehydroepiandrosterone and raloxifene sulfation. Horm. Mol. Biol. Clin. Inves., 1: 81-87.
12. Couzin-Frankel, J., 2009. What role for antiviral drugs. Science, 324: 705-705. DOI: 10.1126/science.324_705
13. Deyde, V.M., X. Xu, R.A. Bright, M. Shaw and C.B. Smith et al., 2007. Surveillance of Resistance to Adamantanes among Influenza A(H3N2) and A(H1N1) Viruses Isolated Worldwide. J. Infect. Dis., 196: 249-257. DOI: 10.1086/518936
14. Du, Q.S., R.B. Huang, S.Q. Wang and K.C. Chou, 2010. Designing inhibitors of M2 proton channel against H1N1 swine influenza virus.
15. Du, Q.S., R.B. Huang, C.H. Wang, X.M. Li. and K.C. Chou 2009. Energetic analysis of the two controversial drug binding sites of the M2 proton channel in influenza a virus. J. Theoretical Biol., 259: 159-164. DOI: 10.1016/j.jtbi.2009.03.003
16. Duff, K.C. and R.H. Ashley, 1992. The transmembrane domain of influenza A M2 protein forms amantadine-sensitive proton channels in planar lipid bilayers. Virology, 190: 485-489. DOI: 10.1016/0042-6822(92)91239-Q
17. Frimurer, T.M., G.H. Peters, L.F. Iversen, H.S. Andersen and N.P Moller et al., 2003. Ligand-induced conformational changes: Improved predictions of ligand binding conformations and affinities. Biophys. J., 84: 2273-2281.
18. Grambas, S. and A.J. Hay, 1992. Maturation of influenza a virus hemagglutinin-estimates of the pH encountered during transport and its regulation by the M2 protein. Virology, 190: 11-18. DOI: 10.1016/0042-6822(92)91187-Y
19. Gordon, J.C., J.B. Myers, T. Folta, V. Shoja and L.S. Heath et al., 2005. H++: A server for estimating pKas and adding missing hydrogens to macromolecules. Nucl. Acids Res., 33: W368-W371. DOI: 10.1093/nar/gki464
20. Huang, R.B., Q.S. Du, C.H. Wang and K.C. Chou, 2008. An in-depth analysis of the biological functional studies based on the NMR M2 channel structure of influenza a virus. Biochem. Biophys. Res. Commun., 377: 1243-1247. DOI: 10.1016/j.bbrc.2008.10.148
21. Holsinger, L.J. and R. Alamb, 1991. Influenza virus M2 integral membrane protein is a homotetramer stabilized by formation of disulfide bonds. Virology, 183: 32-43. DOI: 10.1016/0042-6822(91)90115-R
22. Halgren, T.A., 1990. Maximally diagonal force constants in dependent angle-bending coordinates. II, Implications for the design of empirical force fields. J. Am. Chem. Soc., 112: 4710-4723.
23. Hayden, F.G. and H.J. Hay, 1992. Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine. Curr. Top. Microbiol. Immunol., 176: 119-130. PMID: 1600749
24. Hatta, M., H. Goto and Y. Kawaoka, 2004. Influenza B virus requires BM2 protein for replication. J. Virol., 78: 5576-83. PMID: 15140954
25. Hu, W., S. Zeng, C. Li, Y. Jie and Z. Li et al., 2010. Identification of hits as matrix-2 protein inhibitors through the focused screening of a small primary amine library. J. Med. Chem., 53: 3831-3834. DOI: 10.1021/jm901664a
26. Intharathep, P., C. Laohpongspaisan, T. Rungrotmongkol, A. Loisruangsin and M. Malaisree et al., 2008. How amantadine and rimantadine inhibit proton transport in the M2 protein channel. J. Mol. Graph. Model., 27: 342-348. PMID: 18620883
27. Jing, X., C. Ma, Y. Ohigashi, F.A. Oliveira and T.S. Jardetzky et al., 2008. Functional studies indicate amantadine binds to the pore of the influenza A virus M2 proton-selective ion channel. Proc. Nat. Acad. Sci. USA., 105: 10967-72.
28. Kaminski, G. and W.L. Jorgensen, 1996. Performance of the AMBER94, MMFF94 and OPLS-AA force fields for modeling organic liquids. J. Phys. Chem., 100: 18010-18013. DOI: 10.1021/jp9624257
29. Kumar, S., 2011. Molecular modeling and identification of substrate binding site of orphan human cytochrome P450 4F22. Bioinformation, 7: 207-210.
30. Lipatov, A.S., E.A. Govorkova, R.J. Webby, H. Ozaki and M. Peiris, et al., 2004. Influenza: Emergence and control. J. Virol., 78: 8951-8959. DOI: 10.1128/JVI.78.17.8951-8959.2004
31. Le, L. and J. Leluk, 2011. Study on phylogenetic relationships, variability and correlated mutations in M2 proteins of influenza virus A. PLoS One, 6: e22970-e22970. PMID: 21829678, DOI: 10.1371/journal.pone.0022970
32. Matsubara, T., A. Onishi, T. Saito, A. Shimada and H. Inoue et al., 2010. Sialic acid-mimic peptides as hemagglutinin inhibitors for anti-influenza therapy. J. Med. Chem., 53: 4441-4449. DOI: 10.1021/jm1002183
33. Mazur, P., T. Magdziarz, A. Bak, Z. Chilmonczyk and T. Kasprzycka-Guttman et al., 2009. Does molecular docking reveal alternative chemopreventive mechanism of activation of oxidoreductase by sulforaphane isothiocyanates? J. Mol. Mod., 16: 1205-1212. DOI: 10.1007/s00894-009-0628-5
34. Pielak, R.M., J.R. Schnell and J.J. Chou, 2009. Mechanism of drug inhibition and drug resistance of influenza A M2 channel. Proc. Nat. Acad. Sci., 106: 7379-7384.
35. Pyrkov, T.V., I.V. Ozerov, E.D. Balitskaya and R.G. Efremov, 2010. Molecular docking: The role of noncovalent interactions in the formation of proteinnucleotide and protein-peptide complexes. Russian J. Bioorganic Chem., 36: 446-455 DOI: 10.1134/S1068162010040023
36. Sugrue, R.J. and A.J. Hay, 1991. Structural characteristics of the M2 protein of influenza A viruses: Evidence that it forms a tetrameric channel. Virology, 180: 617-624. PMID: 1989386
37. Shimbo, K., D.L. Brassard, R.A. Lamb and L.H. Pinto, 1996. Ion selectivity and activation of the M2 ion channel of influenza virus. Biophys. J., 70: 1335-1346. DOI: 10.1016/S0006-3495(96)79690-X
38. Smith, B.J., J.L. McKimm-Breshkin, M. McDonald, R.T. Fernley and J.N. Varghese et al., 2002. Structural studies of the resistance of influenza virus neuramindase to inhibitors. J. Med. Chem., 45: 2207-2212. PMID: 12014958
39. Schmidtke, M., R. Zell, K. Bauer, A. Krumbholz, C. Schrader and J. Suess et al., 2006. Amantadine resistance among porcine H1N1, H1N2 and H3N2 influenza a viruses isolated in Germany between 1981 and 2001. Intervirology, 49: 286-293. PMID: 16809934
40. Snow, C.D., E.J. Sorin, Y.M. Rhee and V.S. Pande, 2005. How well can simulation predict protein folding kinetics and thermodynamics? Annual Rev. Biophys. Biomolecular Struct., 34: 43-69. DOI: 10.1146/annurev.biophys.34.040204.144447
41. Trifonov, V., H. Khiabanian and R. Rabadan, 2009. Geographic dependence, surveillance and origins of the 2009 influenza A (H1N1) virus. N. Engl. J. Med., 361: 115-119. DOI: 10.1056/NEJMp0904572
42. Tambunan, U.S.F., A. Limanto and A.A. Parikesit, 2010. In silico analysis of hemagglutinin, neuraminidase and matrix2 of H5N1 virus Indonesian strain related to its high pathogenicity. IIOAB J., 1: 17-24
43. Takeuchi, K. and R.A. Lamb, 1994. Influenza virus M2 protein ion channel activity stabilizes the native form of fowl plague virus hemagglutinin during intracellular transport. J. Virol., 68: 911-919.
44. Tran, L., S.B. Choi, B.O. Al-Najjar, M. Yusuf and H.A. Wahab et al., 2011. Discovery of potential M2 channel inhibitors based on the amantadine scaffold via virtual screening and pharmacophore modeling. Molecules, 16: 10227-10255. DOI: 10.3390/molecules161210227
45. Vilar, S., G. Cozza and S. Moro, 2008. Medicinal chemistry and the Molecular Operating Environment (MOE): Application of QSAR and molecular docking to drug discovery. Curr. Top. Med. Chem., 8: 1555-72. PMID: 19075767
46. Veits, J., S. Weber, O. Stech, A. Breithaupt and M. Graber et al., 2012. Avian influenza virus hemagglutinins H2, H4, H8 and H14 support a highly pathogenic phenotype. Proc. Nat. Acad. Sci. USA., 109: 2579-2584.
47. Wang, J.F., D.Q. Wei and K.C. Chou, 2009. Insights from investigating the interactions of adamantanebased drugs with the M2 proton channel from the H1N1 swine virus. Biochem. Biophys. Res. Commun., 388: 413-417. PMID: 19665993, DOI: 10.1016/j.bbrc.2009.08.026
48. Wang, C., K. Takeuchi, L.H. Pinto and R.A. Lamb, 1993. Ion channel activity of influenza A virus M2 protein: Characterization of the amantadine block. J. Virol., 67: 5585-5594.
49. Wildman, S.A. and G.M. Crippen, 2001. Evaluation of ligand overlap by atomic parameters. J. Chem. Inform. Comput. Sci., 41: 446-450. DOI: 10.1021/ci0000880
50. Wildman, S.A. and G.M. Crippen, 2003. Validation of DAPPER for 3D QSAR: Conformational search and chirality metric. J. Chem. Inform. Comput. Sci., 43: 629-36. DOI: 10.1021/ci0256081
51. Zhou, F. and K. Schulten, 1996. Molecular dynamics study of phospholipase A2 on a membrane surface. Proteins, 25: 12-27. PMID: 8727316